Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Evaluation of CNS xenograft brain tumour response to MRI-guided focused ultrasound in combination with radiation therapy.

British journal of cancer·2026

Same author

Early tumour size changes from neoadjuvant chemotherapy as a predictor of pathologic response in breast cancer.

PloS one·2026

Same author

MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial.

The Lancet. Oncology·2026

Same author

Assessing the benefits of using plane wave compounding when estimating backscatter coefficients with an in situ bead as a calibration target.

The Journal of the Acoustical Society of America·2026

Same author

Machine learning for the prediction of three-year survival in locally advanced breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound imaging.

Scientific reports·2026

Same author

Voting intentions during the later stage of the COVID-19 pandemic: The roles of risk perception and performance evaluations in South Korea.

PloS one·2026

Search research articles

相关实验视频

Updated: May 9, 2026

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

使用CT放射学预测乳腺癌对新辅助化疗的反应

Deok Hyun Jang^1,2,3, Laurentius O Osapoetra^1,2,4, Lakshmanan Sannachi^1,2,4

¹Physical Sciences, Sunnybrook Research Institute, Toronto, ON M4N 3M5, Canada.

|August 28, 2025

概括

这项研究开发了一种机器学习模型,将CT放射特征和临床数据结合起来,以预测乳腺癌患者的新辅助化疗反应,从而能够更早地进行治疗调整.

关键词:

美国乳腺癌机器学习新辅助化疗辐射学响应预测

更多相关视频

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

相关实验视频

Last Updated: May 9, 2026

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

科学领域:

医学成像
癌症学
人工智能

背景情况:

新辅助化疗 (NAC) 的反应对乳腺癌的预后至关重要.
目前的评估依赖于手术后的病理,延迟治疗适应.
预测NAC治疗前的反应对于个性化治疗至关重要.

研究的目的:

开发和验证一个机器学习模型,整合治疗前CT扫描和临床变量中的放射性特征.
预测乳腺癌患者对NAC的病理完整反应 (pCR) 和临床反应.
改善针对个人的乳腺癌治疗疗效的早期预测.

主要方法:

从治疗前对比度增强的CT扫描中提取了214个放射性特征.
将7个临床基线变量纳入预测模型.
开发了一个基于XGBoost的模型,并使用十个独立数据分区的精度,AUC和其他指标评估其性能.

主要成果:

结合的临床-放射性模型在pCR和临床反应预测上显著优于仅使用放射性或临床特征的模型.
对于pCR分类,组合模型的准确度为82. 8%,AUC为0. 846.
对于临床反应分类,组合模型的准确度为71. 7%,AUC为0. 725.

结论:

将CT衍生的放射性特征与临床数据相结合,可提高乳腺癌新辅助化疗反应的预测.
这种方法支持更早,更个性化的治疗决策.
这些发现突显了人工智能驱动的成像分析在优化乳腺癌治疗策略方面的潜力.